All News

influenza-156098_640.png

Influenza Vaccine Updates And Pearls At ACR 2019

d Cassandra Calabrese, DO

As we enter flu season it is of the utmost importance that we remember to assess our patients’ influenza vaccine status at each visit.

Read Article
gout.MTP_.jpg

PANLAR Ultrasound Study Group: Recommendations On Imaging Modalities In Gout

d Olga Petryna, MD

Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.

Read Article
Conv3.jpg

ACR 2019 – Best of the Plenary Sessions

d Jack Cush, MD

The ACR Plenary Sessions featured some of the best research presented on Sunday, Monday, and Tuesday in Atlanta. Here are my seven notable highlights from the Plenaries.

Read Article
vasculitis.digitial.jpg

Hepatitis C-Related Cryoglobulinemic Vasculitis

d David Liew, FRACP

Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.

Read Article
thought-2123970_640.jpg

ACR 2019 - Report from Day One (Sunday)

d Jack Cush, MD

Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one. 



Delays in Diagnosis

Read Article
mri-2813908_640.jpg

MRI in the Diagnosis and Management of Polymyalgia Rheumatica

d Paul Sufka, MD

Polymyalgia rheumatica (PMR) is a common condition seen by both primary care and in the rheumatology office.

Read Article
smiley-2979107_640_0.jpg

Can the Happiest Subspecialists Experience Burnout?

d Kanika Monga, MD

The Medscape’s Physician Lifestyle & Happiness Report 2019 crowned rheumatologists as the happiest subspecialists. We topped the list with 65% of the respondents indicating that they were happy outside of work.

Read Article
needle-1419606_640.jpg

Autoinflammatory Diseases at the ACR Annual Meeting

d Jonathan S. Hausmann, MD

It has been a wonderful year for autoinflammatory diseases at the ACR Annual Meeting.

Read Article
doors-1767563_640.jpg

Part 1:  The “P” in Prednisone stands for Poison...and Other Pearls

d Kathryn H. Dao, M.D.

Everyone has life hacks.  Years of experience and doing the same things repetitively allow us to figure out little tricks to make life easier. A rat in a maze, finding itself at a dead end, will back up and search for a clearing.

Read Article
fitness-3448864_640.jpg

New Treatments in Axial SpA from #ACR2019

d Antoni Chan, MD, PhD

There were new developments in the treatment of axial Spondyloarthritis (AS) at ACR 2019. The first area is on the use of anti-IL17A drugs, secukinumab and ixekizumab in non-radiographic AS. The second area is the use of JAK-1 inhibitor Upadacitinib in radiographic AS.

Read Article
RN.podcast.resized.jpg

RheumNow Podcast – ACR 2019 Round Up (11.15.19)

d Jack Cush, MD

Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.

Read Article

FINCH3: FILGOTINIB studied in this cohort naive to MTX; interesting that safety data looks good! Maybe too early to tell. Abst# 927 https://t.co/AonswiGYG3 https://t.co/q3OU582WbT

Links:

Dr. John Cush RheumNow ( View Tweet)
abstr#0848 - Retrospective study Medicare database to evaluat outcomes of chronic low dose steroids (GCs) in Rheum Dz: n= 246,297, 47% on GCs. Pts on steroids have : 1. ⬆️ use of narcotics (pain) 2. RA 3. ⬆️hosp visits related to infx 4. Less f/u https://t.co/xD8isyKZsz

Links:

Dr. John Cush RheumNow ( View Tweet)

Plenary session shows AA/blacks at higher risk for #SLE & that blacks have 16 fold increased risk for IHD, CVD. CV risk accelerated at yrs 1 & 10. Copy & paste. #ACR19 Abst 805 https://t.co/pW8JdGxCUf https://t.co/lLPTnyTa2z

Links:

Dr. John Cush RheumNow ( View Tweet)
Abstr#1898 #acr19 @kDAO2011. Danish prospective RA registry of pregnancy & offspring n= 816 - kids of moms w/ RA performed a little worse in math grades 2,4,6, 8 compared to peers regardless of maternal seropositivity. No influence by paternal RA. https://t.co/bOBDtjVtfm

Links:

Dr. John Cush RheumNow ( View Tweet)

Klemperer Lecture Dr J James: 25% people have +ANA, but only 5-8% dev an autoimm dz. Why do most ANA+ pts not develope dz, Note that “healthy” ANA+have both inflamm and suppressive CK profiles compared to ANA neg and SLE pts @KDao2011

Dr. John Cush RheumNow ( View Tweet)

Up to 20% of Sjogrens patients may not have sicca symptoms, especially those with CNS dz. Dr. F. Vivino #ACR19

Dr. John Cush RheumNow ( View Tweet)

Abstract L06 shows the efficacy of Emapalumab, an IFN-γ mAb, when given to 9 systemic JIA pts who developed macrophage activation syndrome. Highly effective showing ability to lower steroid use #ACR19 https://t.co/hduMrzWt72

Links:

Dr. John Cush RheumNow ( View Tweet)

The FDA has approved Pfizers new adadliumab biosimilar - Abrilada (adalimumab-afzb), this is the 5th adalimumab biosimilar to be approved (none are commercially available in the USA until 2023). Abrilada is the 25th biosimilar approved in the U.S. https://t.co/Z0tp3D5yOd

Links:

Dr. John Cush RheumNow ( View Tweet)

7-year, 5,179-patient ISCHEMIA study presented at the AHA Meeting shows that stents and CABG offer no advantage over medical management in prevention of death and cardiovascular events. https://t.co/Fk6kypcek9

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×